Serum Dysregulation of IL-36, IL-37, and IL-38 in Pyoderma Gangrenosum: Clinical Correlations and Implications for IL-36R-Targeted Therapy
Magdalena Łyko, Joanna Maj, Klaudia Rubas, Anna Ryguła-Kowalska, Danuta Nowicka-Suszko, Alina Jankowska-Konsur, Alessandro Terrinoni, Hanna Myśliwiec · 2025
Read Serum Dysregulation of IL-36, IL-37, and IL-38 in Pyoderma Gangrenosum: Clinical Correlations and Implications for IL-36R-Targeted Therapy by Magdalena Łyko, Joanna Maj, Klaudia Rubas, Anna Ryguła-Kowalska, Danuta Nowicka-Suszko, Alina Jankowska-Konsur, Alessandro Terrinoni, Hanna Myśliwiec (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732507.txt.
Description
Łyko and co-authors present a 2025 study on a family of immune signals in pyoderma gangrenosum, a rare skin disease of painful chronic ulcers. Blood from forty-four patients and forty healthy controls was tested for six related signals, the IL-36 group and its kin. Bench assays measured each level, and links to clinical features were hunted.
Two attacking signals ran low in patients, while three calming ones ran high. Signal levels tied to each other and to ulcer area in tidy patterns. One attacker fell as ulcer area grew. The authors read the skew as a rationale for drugs that block the IL-36 receptor, already in use for a cousin disease.
Catalog record
| CREATOR | Magdalena Łyko, Joanna Maj, Klaudia Rubas, Anna Ryguła-Kowalska, Danuta Nowicka-Suszko, Alina Jankowska-Konsur, Alessandro Terrinoni, Hanna Myśliwiec |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |